155 related articles for article (PubMed ID: 7942207)
1. Pretreatment with a competitive NMDA antagonist D-CPPene attenuates focal cerebral infarction and brain swelling in awake rats.
Park CK; McCulloch J; Kang JK; Choi CR
Acta Neurochir (Wien); 1994; 127(3-4):220-6. PubMed ID: 7942207
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of D-CPPene, a competitive N-methyl-D-aspartate antagonist in focal cerebral ischemia in the rat.
Park CK; McCulloch J; Kang JK; Choi CR
Neurosci Lett; 1992 Nov; 147(1):41-4. PubMed ID: 1480321
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of a competitive NMDA antagonist (D-CPPene) in feline focal cerebral ischemia.
Chen M; Bullock R; Graham DI; Frey P; Lowe D; McCulloch J
Ann Neurol; 1991 Jul; 30(1):62-70. PubMed ID: 1834008
[TBL] [Abstract][Full Text] [Related]
4. Glutamate receptor antagonists in experimental focal cerebral ischaemia.
McCulloch J; Ozyurt E; Park CK; Nehls DG; Teasdale GM; Graham DI
Acta Neurochir Suppl (Wien); 1993; 57():73-9. PubMed ID: 8421957
[TBL] [Abstract][Full Text] [Related]
5. Do N-methyl-D-aspartate antagonists have disproportionately greater effects on brain swelling than on ischemic damage in focal cerebral infarction?
Park CK; McCulloch J; Jung DS; Kang JK; Choi CR
Acta Neurochir Suppl (Wien); 1994; 60():279-81. PubMed ID: 7976566
[TBL] [Abstract][Full Text] [Related]
6. Experimental stroke and neuroprotection in the aging rat brain.
Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
Stroke; 1995 Jun; 26(6):1072-8. PubMed ID: 7762026
[TBL] [Abstract][Full Text] [Related]
7. Focal cerebral ischemia in the cat: pretreatment with a competitive NMDA receptor antagonist, D-CPP-ene.
Bullock R; Graham DI; Chen MH; Lowe D; McCulloch J
J Cereb Blood Flow Metab; 1990 Sep; 10(5):668-74. PubMed ID: 2166743
[TBL] [Abstract][Full Text] [Related]
8. The effect of age on cerebral oedema, cerebral infarction and neuroprotective potential in experimental occlusive stroke.
Davis M; Mendelow AD; Perry RH; Chambers IR; James OF
Acta Neurochir Suppl (Wien); 1994; 60():282-4. PubMed ID: 7976568
[TBL] [Abstract][Full Text] [Related]
9. Effects of brain oedema in the measurement of ischaemic brain damage in focal cerebral infarction.
Park CK; Kang SG
Acta Neurochir Suppl; 2000; 76():269-71. PubMed ID: 11450022
[TBL] [Abstract][Full Text] [Related]
10. Cerebral oedema following intracerebral haemorrhage: the effect of the NMDA receptor antagonists MK-801 and D-CPPene.
Kane PJ; Cook S; Chambers IR; Mendelow AD
Acta Neurochir Suppl (Wien); 1994; 60():561-3. PubMed ID: 7976650
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the relationship between ischemic damage and brain swelling in frozen brain slices.
Park CK; Jun SS; Cho SH; Kang JK
Acta Neurochir Suppl; 1997; 70():17-9. PubMed ID: 9416265
[TBL] [Abstract][Full Text] [Related]
12. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
13. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: an in vivo magnetic resonance imaging study.
Sauer D; Allegrini PR; Cosenti A; Pataki A; Amacker H; Fagg GE
J Cereb Blood Flow Metab; 1993 Jul; 13(4):595-602. PubMed ID: 8100238
[TBL] [Abstract][Full Text] [Related]
15. Electrical but not chemical kindling increases sensitivity to some phencyclidine-like behavioral effects induced by the competitive NMDA receptor antagonist D-CPPene in rats.
Wlaź P; Ebert U; Potschka H; Löscher W
Eur J Pharmacol; 1998 Jul; 353(2-3):177-89. PubMed ID: 9726648
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of the kappa-agonist enadoline (CI-977) in rat models of focal cerebral ischaemia.
Hayward NJ; McKnight AT; Woodruff GN
Eur J Neurosci; 1993 Jul; 5(7):961-7. PubMed ID: 8281306
[TBL] [Abstract][Full Text] [Related]
17. Neuropathological endpoints in experimental stroke pharmacotherapy: the importance of both early and late evaluation.
Valtysson J; Hillered L; Andiné P; Hagberg H; Persson L
Acta Neurochir (Wien); 1994; 129(1-2):58-63. PubMed ID: 7998497
[TBL] [Abstract][Full Text] [Related]
18. The effect of the kappa-opioid receptor agonist CI-977 in a rat model of focal cerebral ischaemia.
Kusumoto K; Mackay KB; McCulloch J
Brain Res; 1992 Mar; 576(1):147-51. PubMed ID: 1325235
[TBL] [Abstract][Full Text] [Related]
19. The nitric oxide synthase inhibitor L-NAME (N omega-nitro-L-arginine methyl ester) does not produce discriminative stimulus effects similar to ethanol.
Green KL; Gatto GJ; Grant KA
Alcohol Clin Exp Res; 1997 May; 21(3):483-8. PubMed ID: 9161609
[TBL] [Abstract][Full Text] [Related]
20. A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T; Takano K; Meiler MR; Fisher M
Stroke; 1998 Jan; 29(1):190-5. PubMed ID: 9445350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
